Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Hemodynamics and Pulmonary Complications in Heart Valve Surgery
NCT06467513Phase 4Recruiting
- Start
- Jan 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine in postoperative pulmonary complications (PPC). Started Jan 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pulmonary complications (PPC)
Beyond the preview
Go deeper on NCT06467513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06467513.